Purchase Order SPE2DS23V9773
Award Date 8/9/23
Potential Completion Date 8/14/23
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Fenwal, Inc., a global blood technology company, is for the provision of various blood collection and processing products and services. The contract, valued at $3,445.95, was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The contract includes items such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, and other specialized equipment and consumables used in transfusion...
- This federal contract award, valued at $2,202.56, was issued by the Defense Logistics Agency's Medical Supply Chain division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the procurement of blood packs with anticoagulant, classified under the product code 8511121932. This is a firm fixed-price purchase order with a period of performance ending on March 17, 2025. The award does not have a set-aside designation, reflecting Fenwal's...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection and transfusion products. The $3,303.84 contract is for the delivery of blood packs with anticoagulant, which support healthcare and biomedical research initiatives. Fenwal has established itself as a key supplier to various federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Defense...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables for the blood and biomedical research supply chain. The $1,148.65 contract is for the supply of blood collection assemblies and related products to support critical healthcare programs, including military medical supply chains and biomedical research initiatives. The contract has an ultimate...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and supplies. The contract is for the delivery of blood packs with anticoagulant, with a ceiling value of $3,303.84 and a completion date of August 18, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has consistently secured...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical supplies, for the delivery of blood packs with anticoagulant. The contract has a ceiling value of $3,303.84 and an ultimate completion date of August 18, 2025. Fenwal, Inc. is a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The company is a registered vendor with the U.S. federal...
- This federal contract award is for the procurement of a DILUTING SOLUTION,F product by the U.S. government. The contract was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract has a firm fixed price of $1,519.68 and an ultimate completion date of May 20, 2025. It was awarded by the Defense Logistics Agency (DLA), which supports the defense and civilian medical supply chains. Fenwal, Inc. is a registered...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order valued at $3,967.24 to Fenwal, Inc. for a hand blood sealer on November 7, 2025, with an ultimate completion date of December 1, 2025. The contract, issued without set-aside designation, reflects Fenwal's established position as a specialized supplier of blood collection, separation, storage, and transfusion products to federal health agencies. Fenwal, a subsidiary of Fresenius Kabi headquartered...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical devices and supplies. The contract, valued at $1,871.34, is for the delivery of hand-operated blood pack sealers. This award supports critical healthcare programs, including military medical supply chains, biomedical research initiatives, and blood banking operations. Fenwal, Inc. is a registered vendor with the U.S. federal government and...